John Zhang, Ph.D.

John has of 20+ years regulatory health authority expertise. He can help global drug developers create and maintain a consistent, controlled, and compliant manufacturing process for their product in China.

Work experience

Prior to joining Parexel, John was the Chief Reviewer in CMC technical evaluation at the NMPA/CDE. He oversaw site inspections both in API and pharmaceutical products and has expertise in solid/injection/ semi-solid preparations and other complex preparations (Dermatology, Ophthalmology, Inhalation, Topical solution). He also drafted NMPA’s Guidelines on Nano-particle medicines, Topical preparation, Pediatrics Therapeutics, and OTC medicines.

Education

John holds a post-doctorate at Kyoto University, Japan and a Ph.D. in population Pharmacokinetics at the Shenyang Pharmaceutical University / Medical department of Peking University. He is fluent in Chinese and skilled in English and Japanese language.